Literature DB >> 18532920

Pulmonary cell culture models to study the safety and efficacy of innovative aerosol medicines.

Michael Bur1, Claus-Michael Lehr.   

Abstract

BACKGROUND: Pulmonary cell culture models for the development of new aerosol medicines are attracting increasing interest. Ease of handling, ethical acceptance and high explanatory power are the main advantages of cell culture systems in pulmonary drug research.
OBJECTIVE: Pulmonary cell culture models are described and evaluated regarding their suitability for the biopharmaceutical characterisation of innovative aerosol medicines.
METHODS: The review focuses on the peculiarities of the pulmonary cell culture models arising from the specialised pulmonary epithelia, the clearance systems in the lung and the limited but functionalised lung fluid layers. Additional aerosol deposition systems suitable for the close to in vivo simulation of aerosol delivery on pulmonary cell cultures are described.
RESULTS: Suitable cell culture models of the cellular part of the human air-blood barrier are established and well characterised. However, the physical barriers on top of the cellular barriers - surfactant, mucus and so on - and their influence on the safety and efficacy of aerosol medicines, are still underestimated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18532920     DOI: 10.1517/17425247.5.6.641

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  5 in total

1.  Epithelial profiling of antibiotic controlled release respiratory formulations.

Authors:  Hui Xin Ong; Daniela Traini; Mary Bebawy; Paul Michael Young
Journal:  Pharm Res       Date:  2011-05-26       Impact factor: 4.200

Review 2.  Innovative preclinical models for pulmonary drug delivery research.

Authors:  Stephan Ehrmann; Otmar Schmid; Chantal Darquenne; Barbara Rothen-Rutishauser; Josue Sznitman; Lin Yang; Hana Barosova; Laurent Vecellio; Jolyon Mitchell; Nathalie Heuze-Vourc'h
Journal:  Expert Opin Drug Deliv       Date:  2020-02-23       Impact factor: 6.648

3.  In vitro cell integrated impactor deposition methodology for the study of aerodynamically relevant size fractions from commercial pressurised metered dose inhalers.

Authors:  Mehra Haghi; Daniela Traini; Paul Young
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

4.  Ciprofloxacin is actively transported across bronchial lung epithelial cells using a Calu-3 air interface cell model.

Authors:  Hui Xin Ong; Daniela Traini; Mary Bebawy; Paul M Young
Journal:  Antimicrob Agents Chemother       Date:  2013-03-18       Impact factor: 5.191

Review 5.  Optimizations of In Vitro Mucus and Cell Culture Models to Better Predict In Vivo Gene Transfer in Pathological Lung Respiratory Airways: Cystic Fibrosis as an Example.

Authors:  Rosy Ghanem; Véronique Laurent; Philippe Roquefort; Tanguy Haute; Sophie Ramel; Tony Le Gall; Thierry Aubry; Tristan Montier
Journal:  Pharmaceutics       Date:  2020-12-31       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.